Body composition evaluation can present data related to breast most cancers sufferers’ (BCP) prognosis, that may lead interventions to enhance survival outcomes. The intention of this examine was to judge the impact of an individualized vitamin intervention program on breast most cancers sufferers utilizing bioelectrical impedance vector evaluation (BIVA). This is a pretest-posttest examine in not too long ago identified nonmetastatic BCP present process antineoplastic therapy, freed from co-morbidities and dietary supplementation. Body composition was assessed at baseline and 6 months after an individualized vitamin intervention program, by dual-energy X-ray absorptiometry and BIVA.
According to BIVA, every participant was positioned in the bivariate tolerance ellipses for Mexican inhabitants (50%, 75%, and 95%). In medical follow, the 50% and 75% ellipses are thought of inside normality ranges. Nine nonmetastatic BCP accomplished the intervention and have been included in the evaluation. After the intervention, they decreased by 5.eight kg of physique weight (IQR, 3-6; p < 0.05), 3.eight kg of fats mass (IQR, 0.1-4.2; p < 0.05), and 1.Four kg of fat-free mass (IQR, -0.1 to 4; p < 0.05) whereas appendicular skeletal muscle mass remained unchanged (-0.2 kg, IQR, -0.eight to 2.3; p = 0.4). Using BIVA at baseline, 5 contributors have been among the many 50% and 75% ellipses, primarily positioned in the realm comparable to edema and low lean tissue, two in the cachexia quadrant and two in the athletic quadrant (≥95% ellipse).
After 6 months of intervention, six out of 9 contributors have been in the athletic quadrant and eight of 9 BCP have been above the 5° part angle cut-off level. One affected person initially offered cachexia (≥95% ellipse); at postintervention her vector modified to the 50% ellipse. An individualized vitamin intervention program designed for nonmetastatic BCP was efficient to enhance the dietary standing of BCP as assessed by BIVA, due to this fact BIVA could be a great tool to watch adjustments in nonmetastatic BCP physique composition in analysis and medical follow. Quantile regression hyperlinks the entire distribution of an final result to the covariates of curiosity and has turn out to be an essential different to generally used regression fashions.
However, the presence of censored information resembling survival time, usually the primary endpoint in most cancers research, has hampered the usage of quantile regression methods due to the incompleteness of knowledge. With the appearance of the precision drugs period and availability of excessive throughput information, quantile regression with high-dimensional predictors has attracted a lot consideration and supplied added perception in comparison with conventional regression approaches. This paper supplies a sensible information for utilizing quantile regression for proper censored final result information with covariates of low- or high-dimensionality.
The Belgian Virtual Tumorbank: A Tool for Translational Cancer Research .
Biobanks play a crucial position in most cancers analysis by offering top quality organic samples for analysis. However, the supply of tumor samples in single analysis establishments is commonly restricted, particularly for uncommon cancers. In order to facilitate the search for samples scattered amongst completely different Belgian establishments, a nationwide digital tumorbank undertaking was launched and is operational since February 2012. The Belgian Virtual Tumorbank (BVT) community encompasses the tumor biobanks from eleven Belgian college hospitals that acquire and retailer residual human tumor samples domestically and is coordinated by the Belgian Cancer Registry.
A internet software was developed and consists of two modules. The registration module (BVTr) centralizes the tumor pattern information from the native companion biobanks. The catalog module (BVTc) permits researchers to hint the tumor samples in the 11 tumor biobanks. The BVTc accommodates affected person, medical and technical information, however excludes figuring out data to make sure privateness of people. Automatic and handbook controls assure top quality information on the samples requested by scientists for analysis functions in oncology.
Currently, greater than 92,000 registrations can be found in the catalog. Twenty-seven p.c of the residual major tumor samples originate from breast tissue, but additionally much less frequent localisations resembling head and neck (4%), male genital organs (1.7%), and urinary tract (1%) can be found. In addition to the residual tumor tissue samples, additionally different out there materials might be saved and registered by the native biobanks. A main benefit of the BVT community is that the out there information might be linked to the information of the Belgian Cancer Registry for high quality management functions.
The commonest kind is corresponding regular tissue (19%).Other often out there supplies are plasma, blood, serum, DNA, and buffy coat. Even PBMCs, RNA, cytology, and urine can be found in some instances. The BVT catalog is a invaluable supply of data for oncology analysis and the final word purpose is to advertise multidisciplinary most cancers analysis (i.e., pathogenesis, illness prediction, prevention, analysis, therapy, and prognosis) for the advantage of all most cancers sufferers. At the identical time, extra and extra animal fashions have been constructed and used in most cancers analysis.
Application of Animal Models in Cancer Research : Recent Progress and Future Prospects
Animal fashions refers back to the animal experimental objects and associated supplies that may simulate human physique established in medical analysis. As the second-largest illness in phrases of morbidity and mortality after heart problems, most cancers has at all times been the main focus of human consideration everywhere in the world, which makes it a analysis hotspot in the medical area. With the deepening of analysis, the development strategies of most cancers animal fashions have gotten extra and extra various, together with chemical induction, xenotransplantation, gene programming, and so on.
Cancer/Testis Antigen 5.1 (SSX1) Antibody
abx145140-1096tests
Abbexa
10 × 96 tests
Ask for price
Cancer/Testis Antigen 5.1 (SSX1) Antibody
abx145140-596tests
Abbexa
5 × 96 tests
Ask for price
Cancer/Testis Antigen 5.1 (SSX1) Antibody
abx145140-96tests
Abbexa
96 tests
EUR 337.5
Cancer/Testis Antigen 5.1 (SSX1) Antibody
abx238257-100g
Abbexa
100 µg
EUR 350
Cancer/Testis Antigen 5.1 (SSX1) Antibody
abx238257-100ug
Abbexa
100 ug
EUR 661.2
Cancer/Testis Antigen 5.1 (SSX1) Antibody
abx302290-100g
Abbexa
100 µg
EUR 362.5
Cancer/Testis Antigen 5.1 (SSX1) Antibody
20-abx302290
Abbexa
Ask for price
Ask for price
Ask for price
Ask for price
Ask for price
20 ug 50 ug 100 ug 200 ug 1 mg
Cancer/Testis Antigen 5.1 (SSX1) Antibody
abx302290-20g
Abbexa
20 µg
EUR 162.5
Cancer/Testis Antigen 5.1 (SSX1) Antibody
abx302290-50g
Abbexa
50 µg
EUR 250
Cancer/testis Antigen 2 (CTAG2) Antibody
abx027593-400l
Abbexa
400 µl
EUR 518.75
Cancer/testis Antigen 2 (CTAG2) Antibody
abx027593-400ul
Abbexa
400 ul
EUR 627.6
Cancer/testis Antigen 2 (CTAG2) Antibody
abx027593-80l
Abbexa
80 µl
EUR 250
Cancer/testis Antigen 2 (CTAG2) Antibody
abx375499-96tests
Abbexa
96 tests
EUR 337.5
Cancer/testis Antigen 2 (CTAG2) Antibody
abx376324-96tests
Abbexa
96 tests
EUR 225
Cancer/testis Antigen 2 (CTAG2) Antibody
abx344921-100l
Abbexa
100 µl
EUR 250
Cancer/testis Antigen 2 (CTAG2) Antibody
abx344921-50l
Abbexa
50 µl
EUR 187.5
Cancer/testis Antigen 2 (CTAG2) Antibody
20-abx149592
Abbexa
Ask for price
Ask for price
Cancer/Testis Antigen 1A (CTAG1A) Antibody
abx027441-400l
Abbexa
400 µl
EUR 518.75
Cancer/Testis Antigen 1A (CTAG1A) Antibody
abx027441-400ul
Abbexa
400 ul
EUR 627.6
Cancer/Testis Antigen 1A (CTAG1A) Antibody
abx027441-80l
Abbexa
80 µl
EUR 281.25
Cancer/Testis Antigen 1A (CTAG1A) Antibody
abx111352-100l
Abbexa
100 µl
EUR 612.5
Cancer/Testis Antigen 1A (CTAG1A) Antibody
20-abx111352
Abbexa
Ask for price
Ask for price
Cancer/Testis Antigen 1A (CTAG1A) Antibody
abx331930-100ul
Abbexa
100 ul
EUR 510
Cancer/Testis Antigen 1B (CTAG1B) Antibody
abx135754-100tests
Abbexa
100 tests
EUR 175
Cancer/Testis Antigen 1B (CTAG1B) Antibody
20-abx135754
Abbexa
Ask for price
Ask for price
Ask for price
Ask for price
20 ul 50 ul 100 ul 200 ul
Cancer/Testis Antigen 1 (CTAG1B) Antibody
abx433062-100g
Abbexa
100 µg
EUR 387.5
Cancer/Testis Antigen 1B (CTAG1B) Antibody
20-abx171540
Abbexa
Ask for price
Ask for price
Cancer/Testis Antigen 1B (CTAG1B) Antibody
abx171540-1ml
Abbexa
1 ml
EUR 787.5
Cancer/Testis Antigen 1A (CTAG1A) Antibody
20-abx126874
Abbexa
Ask for price
Ask for price
Cancer/Testis Antigen 1B (CTAG1B) Antibody
abx128209-100l
Abbexa
100 µl
EUR 275
Cancer/Testis Antigen 1B (CTAG1B) Antibody
20-abx128209
Abbexa
Ask for price
Ask for price
Ask for price
Ask for price
Ask for price
10 ug 50 ug 100 ug 200 ug 1 mg
Cancer/Testis Antigen 1B (CTAG1B) Antibody
abx128209-1ml
Abbexa
1 ml
EUR 750
Cancer/Testis Antigen 1B (CTAG1B) Antibody
abx128209-200l
Abbexa
200 µl
EUR 337.5
Cancer/Testis Antigen 5.1 (SSX1) Antibody (HRP)
abx316206-100g
Abbexa
100 µg
EUR 362.5
Cancer/Testis Antigen 5.1 (SSX1) Antibody (HRP)
20-abx316206
Abbexa
Ask for price
Ask for price
Ask for price
Ask for price
Ask for price
20 ug 50 ug 100 ug 200 ug 1 mg
Cancer/Testis Antigen 5.1 (SSX1) Antibody (HRP)
abx316206-20g
Abbexa
20 µg
EUR 162.5
Cancer/Testis Antigen 5.1 (SSX1) Antibody (HRP)
abx316206-50g
Abbexa
50 µg
EUR 250
Cancer/Testis Antigen 5.1 (SSX1) Antibody (FITC)
abx316207-100g
Abbexa
100 µg
EUR 362.5
Cancer/Testis Antigen 5.1 (SSX1) Antibody (FITC)
20-abx316207
Abbexa
Ask for price
Ask for price
Ask for price
Ask for price
Ask for price
20 ug 50 ug 100 ug 200 ug 1 mg
Cancer/Testis Antigen 5.1 (SSX1) Antibody (FITC)
abx316207-20g
Abbexa
20 µg
EUR 162.5
Cancer/Testis Antigen 5.1 (SSX1) Antibody (FITC)
abx316207-50g
Abbexa
50 µg
EUR 250
Cancer/Testis Antigen 5.1 (SSX1) Antibody (Biotin)
abx316208-100g
Abbexa
100 µg
EUR 362.5
Cancer/Testis Antigen 5.1 (SSX1) Antibody (Biotin)
20-abx316208
Abbexa
Ask for price
Ask for price
Ask for price
Ask for price
Ask for price
20 ug 50 ug 100 ug 200 ug 1 mg
Cancer/Testis Antigen 5.1 (SSX1) Antibody (Biotin)
abx316208-20g
Abbexa
20 µg
EUR 162.5
Cancer/Testis Antigen 5.1 (SSX1) Antibody (Biotin)
abx316208-50g
Abbexa
50 µg
EUR 250
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1)
MBS6002009-02mL
MyBiosource
0.2(mL
EUR 695
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1)
MBS6002009-5x02mL
MyBiosource
5x0.2mL
EUR 2975
ARMC3 (Cancer/testis antigen 81) Polyclonal Antibody
MBS9238385-01mL
MyBiosource
0.1mL
EUR 415
ARMC3 (Cancer/testis antigen 81) Polyclonal Antibody
MBS9238385-5x01mL
MyBiosource
5x0.1mL
EUR 1841
Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody
CAU21749-100ul
Biomatik Corporation
100ul
EUR 235.2
Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody
CAU21749-200ul
Biomatik Corporation
200ul
EUR 294
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (AP)
MBS6289627-02mL
MyBiosource
0.2mL
EUR 980
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (AP)
MBS6289627-5x02mL
MyBiosource
5x0.2mL
EUR 4250
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (APC)
MBS6289628-02mL
MyBiosource
0.2mL
EUR 980
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (APC)
MBS6289628-5x02mL
MyBiosource
5x0.2mL
EUR 4250
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (FITC)
MBS6289630-02mL
MyBiosource
0.2mL
EUR 980
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (FITC)
MBS6289630-5x02mL
MyBiosource
5x0.2mL
EUR 4250
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (PE)
MBS6289637-02mL
MyBiosource
0.2mL
EUR 980
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (PE)
MBS6289637-5x02mL
MyBiosource
5x0.2mL
EUR 4250
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (Biotin)
MBS6289629-02mL
MyBiosource
0.2mL
EUR 980
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (Biotin)
MBS6289629-5x02mL
MyBiosource
5x0.2mL
EUR 4250
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (MaxLight 405)
MBS6289632-01mL
MyBiosource
0.1mL
EUR 980
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (MaxLight 405)
MBS6289632-5x01mL
MyBiosource
5x0.1mL
EUR 4250
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (MaxLight 490)
MBS6289633-01mL
MyBiosource
0.1mL
EUR 980
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (MaxLight 490)
MBS6289633-5x01mL
MyBiosource
5x0.1mL
EUR 4250
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (MaxLight 550)
MBS6289634-01mL
MyBiosource
0.1mL
EUR 980
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (MaxLight 550)
MBS6289634-5x01mL
MyBiosource
5x0.1mL
EUR 4250
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (MaxLight 650)
MBS6289635-01mL
MyBiosource
0.1mL
EUR 980
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (MaxLight 650)
MBS6289635-5x01mL
MyBiosource
5x0.1mL
EUR 4250
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (MaxLight 750)
MBS6289636-01mL
MyBiosource
0.1mL
EUR 980
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (MaxLight 750)
MBS6289636-5x01mL
MyBiosource
5x0.1mL
EUR 4250
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (Azide free) (HRP)
MBS6289631-02mL
MyBiosource
0.2mL
EUR 980
CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (Azide free) (HRP)
MBS6289631-5x02mL
MyBiosource
5x0.2mL
EUR 4250
Polyclonal Antibody to Cancer/Testis Antigen 1B (CTAG1B)
MBS2026997-01mL
MyBiosource
0.1mL
EUR 175
Polyclonal Antibody to Cancer/Testis Antigen 1B (CTAG1B)
MBS2026997-02mL
MyBiosource
0.2mL
EUR 220
Polyclonal Antibody to Cancer/Testis Antigen 1B (CTAG1B)
MBS2026997-05mL
MyBiosource
0.5mL
EUR 355
Polyclonal Antibody to Cancer/Testis Antigen 1B (CTAG1B)
MBS2026997-1mL
MyBiosource
1mL
EUR 435
Polyclonal Antibody to Cancer/Testis Antigen 1B (CTAG1B)
MBS2026997-5mL
MyBiosource
5mL
EUR 1185
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2)
MBS645319-02mL
MyBiosource
0.2mL
EUR 695
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2)
MBS645319-5x02mL
MyBiosource
5x0.2mL
EUR 2975
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (AP)
MBS6289616-02mL
MyBiosource
0.2mL
EUR 980
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (AP)
MBS6289616-5x02mL
MyBiosource
5x0.2mL
EUR 4250
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (APC)
MBS6289617-02mL
MyBiosource
0.2mL
EUR 980
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (APC)
MBS6289617-5x02mL
MyBiosource
5x0.2mL
EUR 4250
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (Biotin)
MBS6289618-02mL
MyBiosource
0.2mL
EUR 980
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (Biotin)
MBS6289618-5x02mL
MyBiosource
5x0.2mL
EUR 4250
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (FITC)
MBS6289619-02mL
MyBiosource
0.2mL
EUR 980
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (FITC)
MBS6289619-5x02mL
MyBiosource
5x0.2mL
EUR 4250
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (PE)
MBS6289626-02mL
MyBiosource
0.2mL
EUR 980
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (PE)
MBS6289626-5x02mL
MyBiosource
5x0.2mL
EUR 4250
Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody (Human)
4-PAJ316Hu01
Cloud-Clone
Ask for price
Ask for price
Ask for price
Ask for price
Ask for price
20ul 100ul 200ul 1ml 10ml
Description: A Rabbit polyclonal antibody against Human Cancer/Testis Antigen 1B (CTAG1B)
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803)
MBS6007563-01mg
MyBiosource
0.1(mg
EUR 630
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803)
MBS6007563-5x01mg
MyBiosource
5x0.1mg
EUR 2680
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (PE)
MBS6157301-01mL
MyBiosource
0.1(mL
EUR 875
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (PE)
MBS6157301-5x01mL
MyBiosource
5x0.1mL
EUR 3800
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (AP)
MBS6130786-01mL
MyBiosource
0.1(mL
EUR 875
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (AP)
MBS6130786-5x01mL
MyBiosource
5x0.1mL
EUR 3800
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) APC
MBS6136089-01mL
MyBiosource
0.1(mL
EUR 875
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) APC
MBS6136089-5x01mL
MyBiosource
5x0.1mL
EUR 3800
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (HRP)
MBS6151998-01mL
MyBiosource
0.1(mL
EUR 875
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (HRP)
MBS6151998-5x01mL
MyBiosource
5x0.1mL
EUR 3800
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (MaxLight 405)
MBS6289621-01mL
MyBiosource
0.1mL
EUR 980
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (MaxLight 405)
MBS6289621-5x01mL
MyBiosource
5x0.1mL
EUR 4250
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (MaxLight 490)
MBS6289622-01mL
MyBiosource
0.1mL
EUR 980
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (MaxLight 490)
MBS6289622-5x01mL
MyBiosource
5x0.1mL
EUR 4250
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (MaxLight 550)
MBS6289623-01mL
MyBiosource
0.1mL
EUR 980
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (MaxLight 550)
MBS6289623-5x01mL
MyBiosource
5x0.1mL
EUR 4250
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (MaxLight 650)
MBS6289624-01mL
MyBiosource
0.1mL
EUR 980
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (MaxLight 650)
MBS6289624-5x01mL
MyBiosource
5x0.1mL
EUR 4250
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (MaxLight 750)
MBS6289625-01mL
MyBiosource
0.1mL
EUR 980
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (MaxLight 750)
MBS6289625-5x01mL
MyBiosource
5x0.1mL
EUR 4250
Human Cancer/testis antigen 2 (CTAG2)
1-CSB-EP006127HU
Cusabio
Ask for price
Ask for price
Ask for price
Ask for price
Ask for price
Ask for price
10ug 50ug 100ug 200ug 500ug 1MG
Description: Recombinant Human Cancer/testis antigen 2(CTAG2) expressed in E.coli
Human Cancer/testis antigen 2 (CTAG2)
1-CSB-YP006127HUa4
Cusabio
Ask for price
Ask for price
Ask for price
Ask for price
Ask for price
Ask for price
10ug 50ug 100ug 200ug 500ug 1MG
Description: Recombinant Human Cancer/testis antigen 2(CTAG2) expressed in Yeast
Human Cancer/testis antigen 1 (CTAG1A)
1-CSB-EP006125HU
Cusabio
Ask for price
Ask for price
Ask for price
Ask for price
Ask for price
Ask for price
10ug 50ug 100ug 200ug 500ug 1MG
Description: Recombinant Human Cancer/testis antigen 1(CTAG1A) expressed in E.coli
Cancer/Testis Antigen 5.1 (SSX1) Protein
abx262587-10mg
Abbexa
10 mg
EUR 325
Cancer/Testis Antigen 5.1 (SSX1) Protein
abx262587-25mg
Abbexa
25 mg
EUR 6575
Cancer/Testis Antigen 5.1 (SSX1) Protein
abx262587-5mg
Abbexa
5 mg
EUR 225
Human Cancer/testis antigen 1 (CTAG1A)
1-CSB-YP006125HU
Cusabio
Ask for price
Ask for price
Ask for price
Ask for price
Ask for price
Ask for price
10ug 50ug 100ug 200ug 500ug 1MG
Description: Recombinant Human Cancer/testis antigen 1(CTAG1A) expressed in Yeast
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (Biotin)
MBS6141392-01mL
MyBiosource
0.1(mL
EUR 875
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (Biotin)
MBS6141392-5x01mL
MyBiosource
5x0.1mL
EUR 3800
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (FITC)
MBS6146695-01mL
MyBiosource
0.1(mL
EUR 875
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (FITC)
MBS6146695-5x01mL
MyBiosource
5x0.1mL
EUR 3800
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (Azide free) (HRP)
MBS6289620-02mL
MyBiosource
0.2mL
EUR 980
CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (Azide free) (HRP)
MBS6289620-5x02mL
MyBiosource
5x0.2mL
EUR 4250
Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody (Human), PE
4-PAJ316Hu01-PE
Cloud-Clone
Ask for price
Ask for price
Ask for price
Ask for price
Ask for price
20ul 100ul 200ul 1ml 10ml
Description: A Rabbit polyclonal antibody against Human Cancer/Testis Antigen 1B (CTAG1B). This antibody is labeled with PE.
Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody (Human), APC
4-PAJ316Hu01-APC
Cloud-Clone
Ask for price
Ask for price
Ask for price
Ask for price
Ask for price
20ul 100ul 200ul 1ml 10ml
Description: A Rabbit polyclonal antibody against Human Cancer/Testis Antigen 1B (CTAG1B). This antibody is labeled with APC.
Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody (Human), Cy3
4-PAJ316Hu01-Cy3
Cloud-Clone
Ask for price
Ask for price
Ask for price
Ask for price
Ask for price
20ul 100ul 200ul 1ml 10ml
Description: A Rabbit polyclonal antibody against Human Cancer/Testis Antigen 1B (CTAG1B). This antibody is labeled with Cy3.
Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody (Human), HRP
4-PAJ316Hu01-HRP
Cloud-Clone
Ask for price
Ask for price
Ask for price
Ask for price
Ask for price
20ul 100ul 200ul 1ml 10ml
Description: A Rabbit polyclonal antibody against Human Cancer/Testis Antigen 1B (CTAG1B). This antibody is labeled with HRP.
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (MaxLight 550)
MBS6210999-01mL
MyBiosource
0.1(mL
EUR 875
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (MaxLight 550)
MBS6210999-5x01mL
MyBiosource
5x0.1mL
EUR 3800
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (MaxLight 405)
MBS6189649-01mL
MyBiosource
0.1(mL
EUR 875
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (MaxLight 405)
MBS6189649-5x01mL
MyBiosource
5x0.1mL
EUR 3800
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (MaxLight 750)
MBS6232349-01mL
MyBiosource
0.1(mL
EUR 875
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (MaxLight 750)
MBS6232349-5x01mL
MyBiosource
5x0.1mL
EUR 3800
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (MaxLight 490)
MBS6200324-01mL
MyBiosource
0.1(mL
EUR 875
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (MaxLight 490)
MBS6200324-5x01mL
MyBiosource
5x0.1mL
EUR 3800
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (MaxLight 650)
MBS6221674-01mL
MyBiosource
0.1(mL
EUR 875
CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (MaxLight 650)
MBS6221674-5x01mL
MyBiosource
5x0.1mL
EUR 3800
Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody (Human), FITC
4-PAJ316Hu01-FITC
Cloud-Clone
Ask for price
Ask for price
Ask for price
Ask for price
Ask for price
20ul 100ul 200ul 1ml 10ml
Description: A Rabbit polyclonal antibody against Human Cancer/Testis Antigen 1B (CTAG1B). This antibody is labeled with FITC.
Rabbit anti-human cancer/testis antigen 1A polyclonal Antibody
MBS710901-01mL
MyBiosource
0.1mL
EUR 485
In latest years, patient-derived xenotransplantation (PDX) mannequin has turn out to be a analysis hotspot as a result of it could possibly retain the microenvironment of the first tumor and the essential traits of cells. Animal fashions can be utilized not solely to check the biochemical and physiological processes of the incidence and improvement of most cancers in objects but additionally for the screening of most cancers medicine and the exploration of gene remedy. In this paper, a number of essential tumor animal fashions and the applying progress of animal fashions in tumor analysis are systematically reviewed. Finally, mixed with the most recent progress and improvement development in this area, the longer term analysis of tumor animal mannequin was prospected.
